After COVID-19, those of all ages are all being diagnosed with more new health conditions

Publicly released:
International
Image by Tumisu from Pixabay
Image by Tumisu from Pixabay

Children, teens and adults who have had COVID-19 are being diagnosed with a range of new physical and mental health problems months after their infection at higher rates, according to research from Germany. Using healthcare data, the team matched over 150,000 people who had COVID-19 with someone of a similar health profile who hadn't had COVID-19, and compared how they used the healthcare system months after their infection. The researchers say children/teens and adults were 30% and 33% more likely to have documented physical and/or mental health problems after COVID-19 respectively.

Media release

From: PLOS

Peer-reviewed                    Observational study                      People

Long-term physical and mental health outcomes after COVID-19 occur in all ages

People of all age groups are at risk of post-COVID-19 syndrome, a study covering nearly half of the German population found

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

Studies have established that some people infected with COVID-19 suffer long-term health problems following the acute phase of the disease. However, evidence on post-acute (post-COVID-19) syndrome is still limited, especially for children and adolescents.

In the new study, using a healthcare dataset covering nearly half the German population and spanning all of 2019 and 2020, researchers identified patients with a polymerase chain reaction (PCR)-confirmed diagnosis of COVID-19. They then compared the occurrence of pre-specified diagnoses, entered into the medical record at least three months post-infection, in these patients (11,950 children and adolescents and 145,184 adults) to a control cohort of more than 750,000 individuals with matched age, sex and pre-existing medical conditions, without PCR-confirmed COVID-19.

Overall, children and adolescents who had been infected with COVID-19 were 30% more likely than controls to have documented health problems beginning three months or more after infection (436.91 vs 335.98 per 1,000 person-years, IRR=1.30, 95% CI=1.25-1.35, p<0.01). Adults with COVID-19 were 33% more likely than controls to have health problems (615.82 vs 464.15 per 1,000 person-years, IRR=1.33, 95% CI=1.31-1.34, p<0.01). Among children and adolescents, rates of malaise/fatigue/exhaustion, cough and throat/chest pain were the most strongly associated with a prior COVID-19 infection, but rates of headache, fever, abdominal pain, anxiety disorder and depression were also increased. Among adults, smell/taste disturbance, fever, and dyspnea (or difficulty breathing) were most strongly associated with COVID-19 infection but also more common were cough, throat and chest pain, hair loss, fatigue, exhaustion and headache.

“The results of the present study indicate that post-COVID-19 syndrome cannot be dismissed among children and adolescents,” the authors say. “We found that COVID-19 diagnosis was associated with higher long-term demand for healthcare services as reflected in outpatient and inpatient diagnoses of a broad set of outcomes more than three months after confirmed SARS-CoV-2 infection. While children and adolescents appear to be less affected than adults, these findings are statistically significant for all age groups.”

Roessler adds, “The results of our study indicate that people of all age groups, including children and adolescents, are at risk of post-COVID-19 syndrome.”

#####

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page The URL will go live after the embargo ends
Journal/
conference:
PLOS Medicine
Research:Paper
Organisation/s: University Hospital Carl Gustav Carus, Germany
Funder: AV, FE, FT, JJ, JS, JW, MR, MS, and ON report institutional funding for parts of this project from the German BMBF (grant number: 01KX2021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.